Predictors of long-term clinical outcome of patients with acute massive pulmonary embolism after thrombolytic therapy

Chinese Medical Journal

Volumn 116, Issue 4, 2003, Pages 503-509

  Liu, Pinming ^a   Meneveau, Nicolas ^b   Schiele, François ^b   Bassand, Jean Pierre ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

Deep venous thrombosis; Pulmonary embolism; Thrombolytic therapy

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; HEPARIN; OXYGEN; RECOMBINANT PLASMINOGEN ACTIVATOR; STREPTOKINASE; UROKINASE; WARFARIN;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BLEEDING; CONTROLLED STUDY; DEATH; DISEASE COURSE; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; DRUG USE; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HEART RIGHT VENTRICLE FUNCTION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; INFERIOR CAVA VEIN; LUNG ARTERY PRESSURE; LUNG EMBOLISM; LUNG SCINTISCANNING; LUNG VENTILATION; MAJOR CLINICAL STUDY; MALE; MODEL; MORTALITY; PREDICTION; PULMONARY ARTERY OCCLUSION; PULMONARY HYPERTENSION; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICAL ANALYSIS; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; THROMBOEMBOLISM; TREATMENT OUTCOME; VENA CAVA FILTER;

ACUTE DISEASE; AGED; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; THROMBOLYTIC THERAPY;

EID: 0038620374     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Riedel M, Stanek V, Widimsky J, et al. Long-term follow-up of patients with pulmonary thromboembolism: late prognosis and evolution of hemodynamic and respiratory data. Chest 1982;81:151-158.
2. Ribeiro A, Lindmarker P, Johnsson H, et al. L Pulmonary embolism: one-year follow-up with echocardiography doppler and five-year survival analysis. Circulation 1999;99:1325-1333.
3. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353:1386-1389.
4. Meneveau N, Bassand JP, Schiele F, et al. Safety of thrombolytic therapy in elderly patients with massive pulmonary embolism: A comparison with nonelderly patients. J Am Coll Cardiol 1993;22:1075-1079.
5. Meneveau N, Schiele F, Vuillemenot A, et al. Streptokinase vs alteplase in massive pulmonary embolism: a randomized trial assessing right heart hemodynamics and pulmonary vascular obstruction. Eur Heart J 1997;18:1141-1148.
6. Meneveau N, Schiele F, Metz D, et al. Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: immediate clinical and hemodynamic outcome and one-year follow-up. J Am Coll Cardiol 1998:31:1057-1063.
7. Carson JL, Kelley MA, Duff A, et al. The clinical course of pulmonary embolism. N Engl J Med 1992;326:1240-1245.
8. Tebbe U, Graf A, Kamke W, et al. Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism. Am Heart J 1999;138:39-44.
9. Kasper W, Konstantinides S, Geibel A, et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol 1997;30:1165-1171.
10. Konstantinides S, Geibel A, Olschewski M, et al. Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry. Circulation 1997; 96:882-888.
11. Girard P, Musset D, Parent F, et al. High prevalence of detectable deep venous thrombosis in patients with acute pulmonary embolism. Cheat 1999;116:903-908.
12. Ribeiro A, Lindmarker P, Juhlin-Dannfelt A, et al. Echcardiography Doppler in pulmonary embolism: right ventricular dysfunction as a predictor of mortality rate. Am Heart J 1997;134:479-487.
13. Goldhaber SZ, Haire WD, Feldstein ML, et al. Alteplase versus heparin in acute pulmonary embolism: randomized trial assessing right-ventricular function and pulmonary perfusion. Lancet 1993;341:507-511.
14. Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep vein thrombosis. N Eng J Med 1998;338:409-415.
15. Simonneau G, Sors H, Charbonnier B, et al. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. N Engl J Med 1997;337:663-669.